Browsing Tag
Hetero
Phase III trials of Covid-19 drug Movfor show positive results, confirms Hetero
No fatalities were reported during the study, it added.
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine.
The results, presented…
Hetero gets DCGI nod to launch biosimilar version of Tocilizumab
Hetero’s Tocilizumab 400mg/20ml is the biosimilar version of Roche’s Actemra/RoActemra drug. Tocilizumab is distributed by Cipla in India under licence from Roche. (Representational image)The Drug Controller General of India (DCGI) has…
Hetero Labs seeks emergency nod for Covid-19 drug Molnupiravir
Hetero Labs, a Hyderabad-based pharmaceutical company, said on Friday that it has sought an emergency use nod from the local regulator for coronavirus disease (Covid-19) drug Molnupiravir, after interim data from a late-stage trial showed…